-
Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1960 in its research report dated September 23, 2025.
-
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 1960 in its research report dated July 31, 2025.
-
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1875 in its research report dated August 01, 2025.
-
Deven Choksey recommended accumulate rating on Sun Pharmaceutical Industries with a target price of Rs 1811 in its research report dated May 28, 2025.
-
Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 2000 in its research report dated May 23, 2025.
-
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 2000 in its research report dated May 23, 2025.
-
Emkay Global Financial is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated April 10, 2025.
-
ICICI Securities is bullish on Sun Pharmaceutical Industries recommended buy rating on the stock with a target price of Rs 1895 in its research report dated March 11, 2025.
-
KR Choksey recommended Accumulate rating on Sun Pharmaceutical Industries with a target price of Rs 1967 in its research report dated February 04, 2024.
-
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 2275 in its research report dated February 01, 2025.
-
Emkay Global Financial is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated January 21, 2025.
-
KR Choksey recommended accumulate rating on Sun Pharmaceutical Industries with a target price of Rs 1967 in its research report dated October 30, 2024.
-
Sharekhan is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2264 in its research report dated October 28, 2024.
-
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 2100 in its research report dated October 29, 2024.
-
KR Choksey recommended accumulate rating on Sun Pharmaceutical Industries with a target price of Rs 1827 in its research report dated August 13, 2024.
-
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 1980 in its research report dated August 01, 2024.
-
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1885 in its research report dated August 01, 2024.
-
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 1810 in its research report dated May 22, 2024.
-
ICICI Securities recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 1463 in its research report dated May 23, 2024.
-
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 1,870 in its research report dated April 23, 2024.
-
KR Choksey is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1827 in its research report dated March 19, 2024.
-
Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1727 in its research report dated March 11, 2024.
-
Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1635 in its research report dated January 31, 2024.
-
ICICI Securities recommended hold rating on Sun Pharma with a target price of Rs 1400 in its research report dated January 31, 2024.
-
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1640 in its research report dated February 01, 2024.
